ADRB2 and heart failure: Recent studies have found that ISO promotes the progression of heart failure by inducing MD2 activation in cardiomyocytes via the β1-AR-cAMP-PKA-ROS signalling axis and inflammatory responses in macrophages via the β2-AR-cAMP-PKA-ROS axis.